A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC)

Publication Date

2025

Content Type

Article

PubMed ID:

40898159

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS